Institutional investors purchased a net $13.3 thousand shares of MNOV during the quarter ended March 2014. This may signal that the smart money is gaining interest in this company as the 4.18% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 15.8 Thousand shares of MediciNova Inc
CITADEL ADVISORS LLC Bought 15.3 Thousand shares of MediciNova Inc